202 related articles for article (PubMed ID: 10150262)
1. A comparison of ampicillin/sulbactam and cefoxitin in the treatment of bacterial skin and skin-structure infections.
Weigelt JA
Adv Ther; 1994; 11(4):183-91. PubMed ID: 10150262
[TBL] [Abstract][Full Text] [Related]
2. Ampicillin/sulbactam and cefoxitin in the treatment of cutaneous and other soft-tissue abscesses in patients with or without histories of injection drug abuse.
Talan DA; Summanen PH; Finegold SM
Clin Infect Dis; 2000 Aug; 31(2):464-71. PubMed ID: 10987706
[TBL] [Abstract][Full Text] [Related]
3. Ampicillin/sulbactam versus cefazolin or cefoxitin in the treatment of skin and skin-structure infections of bacterial etiology.
Chan JC
Adv Ther; 1995; 12(2):139-46. PubMed ID: 10150324
[TBL] [Abstract][Full Text] [Related]
4. Ampicillin/sulbactam compared with cefotaxime in the treatment of lower respiratory tract infections of bacterial etiology.
Jauregui L; Minns P; Hageage G
Adv Ther; 1995; 12(1):62-71. PubMed ID: 10150322
[TBL] [Abstract][Full Text] [Related]
5. A comparison of ampicillin/sulbactam versus cefotaxime in the therapy of lower respiratory tract infections in hospitalized patients.
Jauregui L; Minns P; Hageage G
J Chemother; 1995 Apr; 7(2):153-6. PubMed ID: 7666123
[TBL] [Abstract][Full Text] [Related]
6. A comparison of ampicillin/sulbactam and cefuroxime in the treatment of patients with bacterial infections of the lower respiratory tract.
Geckler RW
Clin Ther; 1994; 16(4):662-72. PubMed ID: 7982254
[TBL] [Abstract][Full Text] [Related]
7. Ampicillin-sulbactam versus cefoxitin for prophylaxis in high-risk patients undergoing abdominal surgery.
Paladino JA; Rainstein MA; Serrianne DJ; Przylucki JE; Welage LS; Collura ML; Schentag JJ
Pharmacotherapy; 1994; 14(6):734-9. PubMed ID: 7885978
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic interchange of ampicillin-sulbactam for cefoxitin.
Lawrenz CA; Cole P; Theodorou A; Cook RL; Bermann L
Am J Hosp Pharm; 1991 Oct; 48(10):2150-4. PubMed ID: 1781470
[TBL] [Abstract][Full Text] [Related]
9. Ampicillin/sulbactam vs. clindamycin/gentamicin in the treatment of postpartum endometritis.
Gall S; Koukol DH
J Reprod Med; 1996 Aug; 41(8):575-80. PubMed ID: 8866384
[TBL] [Abstract][Full Text] [Related]
10. Sulbactam/ampicillin versus cefoxitin for uncomplicated and complicated acute pelvic inflammatory disease.
Hemsell DL; Heard MC; Hemsell PG; Nobles BJ
Drugs; 1988; 35 Suppl 7():39-42. PubMed ID: 3220008
[TBL] [Abstract][Full Text] [Related]
11. Single-agent therapy for acute pelvic inflammatory disease: sulbactam/ampicillin versus cefoxitin.
Hemsell DL; Bawdon RE; Hemsell PG; Nobles BJ; Heard MC
J Int Med Res; 1990; 18 Suppl 4():85D-89D. PubMed ID: 2282973
[TBL] [Abstract][Full Text] [Related]
12. Randomized comparison of ampicillin-sulbactam to cefoxitin and doxycycline or clindamycin and gentamicin in the treatment of pelvic inflammatory disease or endometritis.
McGregor JA; Crombleholme WR; Newton E; Sweet RL; Tuomala R; Gibbs RS
Obstet Gynecol; 1994 Jun; 83(6):998-1004. PubMed ID: 8190448
[TBL] [Abstract][Full Text] [Related]
13. [Acute bacterial salpingitis. The importance of residual inflammation. A comparative study with celioscopic control of 2 antibiotic protocols: sulbactam-ampicillin versus cefoxitin].
Le Bouedec G; Pouly JL; Mage G; Canis M; Wattiez A; Abbas Muhktar B; Bruhat MA
J Gynecol Obstet Biol Reprod (Paris); 1990; 19(6):765-72. PubMed ID: 2147930
[TBL] [Abstract][Full Text] [Related]
14. Pharmacoeconomic analysis of ampicillin-sulbactam versus cefoxitin in the treatment of intraabdominal infections.
Messick CR; Mamdani M; McNicholl IR; Danziger LH; Rodvold KA; Condon RE; Walker AP; Edmiston CE
Pharmacotherapy; 1998; 18(1):175-83. PubMed ID: 9469691
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of ampicillin/sulbactam and cefuroxime in the treatment of serious skin and skin structure infections in pediatric patients. UNASYN Pediatric Study Group.
Azimi PH; Barson WJ; Janner D; Swanson R
Pediatr Infect Dis J; 1999 Jul; 18(7):609-13. PubMed ID: 10440436
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the pharmacodynamic activity of cefotaxime plus metronidazole with cefoxitin and ampicillin plus sulbactam.
Sullivan MC; Nightingale CH; Quintiliani R; Sweeney KR
Pharmacotherapy; 1995; 15(4):479-86. PubMed ID: 7479201
[TBL] [Abstract][Full Text] [Related]
17. Comparative clinical study of Sulbactam and ampicillin and clindamycin and tobramycin in infections of soft tissues.
Stromberg BV; Reines HD; Hunt P
Surg Gynecol Obstet; 1986 Jun; 162(6):575-8. PubMed ID: 3012808
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of a beta-lactamase inhibitor combination for serious intraabdominal infections.
Walker AP; Nichols RL; Wilson RF; Bivens BA; Trunkey DD; Edmiston CE; Smith JW; Condon RE
Ann Surg; 1993 Feb; 217(2):115-21. PubMed ID: 8439209
[TBL] [Abstract][Full Text] [Related]
19. Infectious complications after 809 biliary tract operations and results of a prospective randomized single-blind study comparing cefoxitin versus ampicillin plus an inhibitor of beta-lactamases.
Wittmann DH; Koltowski P; Oleszkiewicz J; Walker AP
Infection; 1990; 18(1):41-7. PubMed ID: 2179137
[TBL] [Abstract][Full Text] [Related]
20. A randomized controlled trial of ampicillin plus sulbactam vs. gentamicin plus clindamycin in the treatment of intraabdominal infections: a preliminary report. Study Group of Intraabdominal Infections.
Rev Infect Dis; 1986; 8 Suppl 5():S583-8. PubMed ID: 2879345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]